According to Acceleron Pharma's latest financial reports the company's current revenue (TTM) is HK$0.87 B. In 2020 the company made a revenue of HK$0.72 B an increase over the revenue in the year 2019 that were of HK$0.57 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.